Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-09

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment

NCT02656095

Lipoprotein Lipase Deficiency

COMPLETED

MLCT Oil for Fatty Liver - PASS Trial

NCT05217745

Non-Alcoholic Fatty Liver Disease Non-Alcoholic Steatohepatitis NAFLD

UNKNOWN NA

Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies

NCT01448577

Lipoprotein Lipase Deficiency

UNKNOWN

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

NCT01447901

Hyperlipoproteinemia Type I

TERMINATED

In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects

NCT05569928

Familial Hypobetalipoproteinemia Familial Hypobetalipoproteinemia - Heterozygous Form

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aims of this study are to (1) assess the feasibility of using these educational videos about LILAC-for-Lp(a) to help improve confidence, testing and the management of Lp(a), (2) assess the acceptability in using short education videos about LILAC-for-Lp(a) and (3) to understand the knowledge gaps of Lp(a) in medical professionals through the additional questionnaire provided.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipoprotein(a) Lipoprotein(a), Hyper-Lp(a)-Emia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthcare Professionals

This group includes participants who are doctors, nurses, pharmacists, allied health and healthcare related students

No interventions assigned to this group

Patients/Family/Public

This group includes participants who have high Lipoprotein(a) levels, or their family members, or members of the public.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants include students, participants from institute of higher learning aged 16 and above.
* Participants aged 16 and above regardless of local or overseas, may also be from educational talks that Dr Loh is invited to speak at.
* Patients and members of the public aged 16 and above if they attend lipid awareness educational events.
* Participants aged 16 and above in patient support groups or patient advocacy networks.